Fructose May Help Ovarian Cancer Spread After Chemo, New Study Finds

The same chemotherapy that fights ovarian cancer may also help it spread. That is the unsettling possibility raised by a new study of cisplatin, a standard treatment for the most common and deadly form of the disease.

Cisplatin, a platinum-based chemotherapy, pushes cancer cells into a dormant, zombie-like state called senescence. Those senescent cells then release a mix of chemical signals into their surroundings. Rather than remaining harmless, those signals encourage nearby cancer cells to break free from tumors and travel to other parts of the body. Making matters worse, the new study in Nature Aging found that fructose, a sugar in fruit, honey, high-fructose corn syrup, and countless processed foods, is central to that process, and that a high-fructose diet increased cancer spread in animal models.

This is not a reason to avoid chemotherapy. Platinum-based chemotherapy remains a standard treatment for high-grade serous ovarian cancer. These findings come mainly from cells and mice and do not show that patients should change their treatment or diet, but they raise new questions about whether either could reduce the damage.

How Chemotherapy Can Backfire Against Ovarian Cancer

Cellular senescence is a state in which cells stop dividing but do not die. Scientists once considered this a helpful response to cancer treatment, a way of freezing dangerous cells in place. Over the past decade, that picture has grown more complicated. Senescent cells secrete a broad mix of chemical signals that can stimulate tumor growth and spread to neighboring cells.

What this research adds is a map of how that process unfolds specifically in high-grade serous ovarian cancer. By analyzing gene activity in cancer patients before and after chemotherapy and by conducting lab and animal experiments, the team confirmed that cisplatin reliably induces ovarian cancer cells into this dormant state. More importantly, they showed that the chemical signals those senescent cells release are enough on their own to drive cancer spread.

In one experiment, researchers collected only the fluid secreted by senescent cancer cells and injected it into mice with ovarian tumors. Injecting that fluid three times per week increased tumor spread to the lining of the abdomen, the intestines, fat tissue, and the omentum, a fatty fold of tissue inside the abdomen that is a common landing spot for ovarian cancer. Rates of tumor cell death and growth did not change meaningfully, suggesting detachment and migration as the mechanism at work.

Fructose as an Unexpected Culprit in Ovarian Cancer Spread

When the team dug into what specifically was driving cancer cells to break free, they found something unexpected. Most prior research has blamed proteins and inflammatory molecules. But filtering out nearly all proteins and large particles from the fluid still produced the same spreading effect. Something small, a metabolite rather than a protein, was doing the work.

Chemical analysis showed that the fluid from senescent cells contained more fructose than fluid from normal cells. Senescent cells appear to consume large amounts of glucose, and that excess glucose gets converted into fructose through a well-described biological process. When researchers added fructose alone to cancer cells that had never been exposed to senescent fluid, it was enough to trigger the same breakaway behavior. And when they blocked the enzymes cells use to process fructose, the breakaway effect disappeared.

To test whether dietary fructose could matter in the real world, the team gave mice fructose in their drinking water and then implanted ovarian cancer cells. High dietary fructose increased cancer spread. In a group of ovarian cancer patients, higher fructose levels in the blood before treatment lined up with more advanced disease at diagnosis, even after accounting for age and body weight.

Tracing the Chain From Fructose to Cancer Spread

Following the path from fructose to cancer spread, researchers pinpointed one protein: NDUFA5, part of the machinery cells use to make energy. Using a gene-editing screen, they found NDUFA5 was required for the spreading effect driven by the senescent fluid.

In plain terms, fructose appears to increase activity in the cells’ energy-making machinery. That activity produces more NAD+, which switches on proteins called sirtuins. The sirtuins then suppress SREBP1, a regulator that normally helps cells make cholesterol. With less cholesterol in their outer membrane, the cancer cells become less firmly anchored and more likely to detach.

Disrupting NDUFA5 or blocking other points along the pathway reduced detachment in lab experiments, and adding cholesterol back helped cells stay attached. Restoring NAD+ with nicotinic acid had the opposite effect: it restored the detachment response in cells lacking NDUFA5. Mice with cancer cells engineered to lack NDUFA5 showed less tumor spread even when given the high-fructose fluid.

That effect was not limited to cisplatin or to ovarian cancer cells. Senescent fluid from carboplatin-treated ovarian cancer cells, cisplatin-treated melanoma cells, gemcitabine-treated pancreatic cancer cells, and even normal aging connective tissue cells all increased cancer cell detachment. The pattern may reach across multiple cancer types and treatment regimens.

What This Could Mean for Future Ovarian Cancer Treatment

The results point to several directions for future research. Drugs that selectively clear out senescent cells are already being studied in cancer and are one possible strategy. Restricting fructose during or after chemotherapy is another idea the authors raise, though they are careful to note it needs testing in clinical settings. The team also ran a cell experiment with nicotinic acid, an NAD+ precursor, and found it restored the detachment response in cancer cells whose NDUFA5 had been disabled. The authors did not test NAD+ supplements in patients, so the finding should not be used to draw conclusions about supplement use in people.

Decades of research have focused on improving chemotherapy’s ability to kill cancer cells. This work makes the case that what those dying and dormant cells release into their surroundings may matter just as much as the killing itself.

Disclaimer: This article describes early research conducted in laboratory cells and animal models, along with a correlation observed in patient blood samples. The findings have not been tested in clinical trials and do not establish that fructose causes cancer spread in people or that any dietary or treatment change is warranted. Anyone with questions about cancer treatment or diet should consult their oncologist.

---